Table 1.
Characteristics of patients with childhood nephrotic syndrome diagnosed between 2006 and 2012 in the Atlanta MSA.
| Characteristic | SSNS (n = 23) | FRNS/SDNS (n = 48) | SRNS (n = 16) | Total (n = 87) |
|---|---|---|---|---|
| Sex | ||||
| Male | 17 (74) | 32 (67) | 9 (56) | 58 (67) |
| Female | 6 (26) | 16 (33) | 7 (44) | 29 (33) |
| Age at diagnosis | ||||
| 1–5 years | 17 (74) | 27 (56) | 3 (19) | 47 (54) |
| 6–12 years | 6 (26) | 15 (31) | 5 (31) | 26 (30) |
| 13–18 years | 0 (0) | 6 (13) | 8 (50) | 14 (16) |
| Race and ethnicity | ||||
| White, non-Hispanic | 6 (26) | 15 (31) | 2 (13) | 23 (26) |
| Black | 7 (30) | 19 (40) | 13 (81) | 39 (45) |
| White, Hispanic | 4 (17) | 9 (19) | 1 (6) | 14 (16) |
| Other | 6 (26) | 5 (10) | 0 (0) | 11 (13) |
| Insurance | ||||
| Private | 11 (48) | 22 (46) | 6 (38) | 39 (45) |
| Medicaid | 11 (48) | 23 (48) | 8 (50) | 42 (48) |
| None | 1 (4) | 3 (6) | 2 (13) | 6 (7) |
| Histopathology | ||||
| No biopsy | 22 (96) | 27 (56) | 2 (13) | 51 (59) |
| MCD | 0 (0) | 17 (35) | 5 (31) | 22 (25) |
| FSGS | 1 (4) | 1 (2) | 6 (38) | 8 (9) |
| Other | 0 (0) | 3 (6) | 3 (19) | 6 (8) |
| Comorbidity | ||||
| None | 19 (83) | 40 (83) | 11 (69) | 70 (80) |
| Asthma | 3 (13) | 7 (15) | 1 (6) | 11 (13) |
| Epilepsy | 1 (4) | 0 (0) | 2 (13) | 3 (3) |
| Inflammatory bowel disease | 0 (0) | 1 (2) | 1 (6) | 2 (2) |
| Prematurity | 0 (0) | 2 (4) | 0 (0) | 2 (2) |
| Other | 1 (4) | 1 (2) | 1 (6) | 3 (3) |
Data are presented as the number of patients with the percentage in parenthesis.
FRNS, frequently relapsing nephrotic syndrome; MCD, minimal change disease; FSGS, focal segmental glomerulosclerosis; SDNS, steroid-dependent nephrotic syndrome; SRNS, steroid-resistant nephrotic syndrome; SSNS, steroid-sensitive and infrequently relapsing nephrotic syndrome.